Page last updated: 2024-09-03

ym 529 and mevalonic acid

ym 529 has been researched along with mevalonic acid in 3 studies

Compound Research Comparison

Studies
(ym 529)
Trials
(ym 529)
Recent Studies (post-2010)
(ym 529)
Studies
(mevalonic acid)
Trials
(mevalonic acid)
Recent Studies (post-2010) (mevalonic acid)
14023713,81033922

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iguchi, T; Ikeda, Y; Kizaki, M; Miyakawa, Y; Yamamoto, K1
Fujiwara, I; Magae, J; Mizuta, M; Mizuta, N; Nakajima, H; Sakaguchi, K; Sawai, K; Tsuruga, M; Yamagishi, H1
Aoyama, K; Kimoto, A; Minamide, T; Miyata, K; Mori, H; Mori, M; Nozaki, K; Sasamata, M; Shimizu, K; Shimokawa, K; Suzuki, H; Tanaka, M; Usui, T; Yamamotoya, H1

Reviews

1 review(s) available for ym 529 and mevalonic acid

ArticleYear
Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis.
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2009, Volume: 134, Issue:3

    Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Geranyltranstransferase; GTP-Binding Proteins; Humans; Imidazoles; Mevalonic Acid; Osteoporosis; Spinal Fractures

2009

Other Studies

2 other study(ies) available for ym 529 and mevalonic acid

ArticleYear
Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway.
    Cellular signalling, 2003, Volume: 15, Issue:7

    Topics: Apoptosis; Cell Division; Cell Line, Tumor; Checkpoint Kinase 1; Diphosphonates; Diterpenes; Enzyme Inhibitors; Farnesol; Humans; Imidazoles; Interleukin-6; MAP Kinase Signaling System; Mevalonic Acid; Multiple Myeloma; Phosphorylation; Protein Kinases; S Phase; Signal Transduction; Stromal Cells

2003
Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate.
    Cancer letters, 2007, Aug-08, Volume: 253, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Breast Neoplasms; Diphosphonates; Drug Screening Assays, Antitumor; Humans; Imidazoles; Mevalonic Acid; Mitochondria; Polyisoprenyl Phosphates; Sesquiterpenes; Signal Transduction

2007